Theme: Taking on challenges and exploring opportunities to achieve Compliance and ensuring great Quality Products

GMP Summit 2016

Renowned Speakers

GMP Summit 2016

Conference Series LLC Conferences invites all the participants from all over the world to attend ‘5th International Summit on GMP, GCP & Quality Control (GMP Summit 2016)' during August 12-13, 2016 at Toronto, Canada which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality.

The main theme of the conference is “Taking on challenges and exploring opportunities to achieve Compliance and ensuring great Quality Products”.

GMP Summit 2016 is the learning of ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Advanced studies are being made to improvise quality of products, reduce safety risk and cost, and enhance international credibility and public image and many more.

Conference Series LLC organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 70000 eminent personalities, reputed scientists as editorial board members.

Track-1: Good Manufacturing Practices: The Gap Within

Good Manufacturing Practice is the part of quality management which ensures that products are consistently produced and controlled according to the quality standards appropriate to their intended use and as required by the marketing authorization, clinical trial authorization or product specification. Good Manufacturing practices conference aims at both production and Quality Control. Current Good Manufacturing Practices (cGMP) is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety and efficacy of products. FDA regulates the quality of pharmaceuticals very carefully. Current Trends in the FDA is the main regulatory standard for ensuring pharmaceutical quality.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; 2016; ICPM 2016 : 18th Conference on Pharmaceutical Manufacturing, July 25-26, 2016, Paris, France; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; eLearning Good Manufacturing Practice (GMP), September 26-27, 2016   London, UK; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Austrian Pharmaceutical Society (APS).

Track-2: Current Regulations and Quality Standards

Roles of pharmaceutical inspection convention and co-operation scheme (PIC/S) are to improve co-operation in the field of Good Manufacturing Practices between regulatory authorities and the pharmaceutical industry. The FDA regulations and CFR are responsible for protecting and promoting public health through the regulation and supervision of all the products available in the market to ensure patient compliance. EU-GMP guidelines are needed to maintain the products quality which is stricter when compared to WHO-GMP guidelines.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston,  USA; ICPRA 2016 : 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; 22nd Asia Pacific Quality Conference, November 20-23, 2016, Rotorua, New Zealand; eLearning Good Manufacturing Practice (GMP), September 26-27, 2016   London, UK; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Canadian Society for Pharmaceutical Sciences (CSPS), Drug Information Association (DIA), International Society for Pharmaceutical Engineering (ISPE), National Association of Pharmacy Regulatory Authorities (NAPRA), Pharmaceutical Research and Manufacturers of America (PhRMA).

Track-3: Current GMP Guidelines (cGMP)

CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US FDA. CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th Biologics and Biosimilars Conference, October 19-21, 2016, Houston,Texas, USA; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Regulatory Affairs Professionals Society (RAPS), Food & Drug Administration (FDA) ,The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-4: The Role of 'c' in cGMP

The CGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement. Accordingly, the "C" in CGMP stands for "current," requiring companies to use technologies and systems that are up-to-date in order to comply with the regulations. Systems and equipment that may have been "top-of-the-line" to prevent contamination, mix-ups, and errors 10 or 20 years ago may be less than adequate by today's quality standards.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston,  USA; 18th Conference on Pharmaceutical Manufacturing, July 25-26, 2016, Paris, France; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; Compliance Online Pharma Summit 2016 – Risk Control and Compliance, October 6-7, 2016, Philadelphia, USA; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Regulatory Affairs Professionals Society (RAPS), Food & Drug Administration (FDA) ,The European Federation of Pharmaceutical Industries and Associations (EFPIA), National Association of Pharmacy Regulatory Authorities (NAPRA), Pharmaceutical Research and Manufacturers of America (PhRMA).

Track-5: Good Clinical Practices and Good Laboratory Practices

The role of ICH in designing GCP principles is to provide an ethical treatment to the subjects who are involved in the clinical trials. Conference on Good Clinical Practices is important because it is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The GLP Principles describe requirements for and provide general guidance on the conduct of all nonclinical health and environmental safety studies, including invitro studies. Pre-clinical trials assess the toxicity of a drug and examine its potential effects on the human body. These trials are conducted in-vitro which is required to proceed with clinical trials. Good laboratory practices should be followed for these pre-clinical trials.

Related Conferences:

7th Conference on Pharmacovigilance, August 22-24, 2016, Vienna, Austria; 3rd  World Congress on Pharmacology, August 08-10, 2016, Birmingham, UK; 2nd Clinical Trials Conference, August 22-24, 2016, Philadelphia, USA; 6th Pharmacovigilance Congress, September 28-30, 2016, Toronto, Canada; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 2nd Pharmacovigilance Conference 2016, June 14-15, 2016, London UK; Canada Talks Pharma 2016: A New Way Forward in Clinical Trials, May 25-26, 2016, Montreal, Canada; CTMD 2016 — The 2nd Congress on Clinical Trials for Medical Devices, September 21-22, 2016, Berlin, Germany; WCTD2016 — The World Congress on Clinical Trials in Diabetes, Nov 30-Dec 01, 2016, Berlin, Germany; Managing Outsourced Clinical Trials, January 25-26, 2017, Miami, USA. The European Personalized Medicine Association (EPEMED), The Institute of Clinical Research (ICR), The BioIndustry Association (BIA), Canadian Generic Pharmaceutical Association (CGPA), The British Generic Manufacturers Association.

Track-6: Quality Control

Quality control (QC) is a procedure or set of procedures intended to ensure that a manufactured product or performed service adheres to a defined set of quality criteria that meets the requirements of the client or customer. A major aspect of quality control is the establishment of well-defined controls. These controls help standardize both production and reactions to quality issues. The role of Quality Impact Assessment & effectiveness checks is an essential operation of the pharmaceutical industry. To Perform Quality Control process of Project Management several quality control tools and software’s are required. Quality control also plays a major role in analytical method development so it would be great to attend the quality control summit.

Related Conferences:

7th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; Annual Pharmaceutical Analysis Conference, Sep 25-27, 2017, Vienna, Austria; 2nd  Separation Techniques Conference, Oct 31 - Nov 2, 2016,  Valencia, Spain; Pharmaceutical Methods Development and Validation Conference, November 24-25, 2016, Dubai, UAE; 3rd Conference on Mass spectrometry, October 10-11, 2016, Kuala Lumpur, Malaysia; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; Convention on Quality Control Circles (ICQCC 2016), August 23-26, 2016, Bangkok, Thailand; 22nd Asia Pacific Quality Conference, November 20-23, 2016, Rotorua, New Zealand; 22nd Symposium on Quality Function Deployment, September 07-16, 2016, Boise, USA. Generic Pharmaceutical Association, National Association of Pharmaceutical Manufacturers, European Generic medicines Association, Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC).

Track-7: Quality Assurance

Quality assurance is defined as a procedure or set of procedures intended to ensure that a product or service under development meets specified requirements. A quality assurance system is said to increase customer confidence and a company's credibility, to improve work processes and efficiency, and to enable a company to better compete with others. Quality assurance conferences aims at the need for Effective Internal and External Quality Assurance Auditing and it is required, by all active pharmaceutical ingredient (API)/bulk pharmaceutical chemical, medical device and finished pharmaceutical cGMP regulations published worldwide. Quality assurance testing is done by using software called Quality Metrics.

Related Conferences:

7th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; Annual Pharmaceutical Analysis Conference, Sep 25-27, 2017, Vienna, Austria; 2nd Separation Techniques Conference, Oct 31 - Nov 2, 2016,  Valencia, Spain; Middle East Surgical and Medical Devices Expo, October 10-12, 2016, Dubai, UAE; Pharmaceutical Method Development and Validation Conference, November 24-25, 2016, Dubai, UAE; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; Data Integrity Validation, September 17-18, 2016, San Diego, CA; IVT’s 2nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Japan Generic Pharmaceutical Manufacturers Association, Association of the British Pharmaceutical Industry, Pharmaceutical Association for the Development of the Republic of China (CPMDA), The Danish Association of the Pharmaceutical Industry, Belgian Pharmaceutical Industry Association.

Track-8: Validation

Validation means establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes. Validation is an integral part of quality assurance; it involves the systematic study of systems, facilities and processes aimed at determining whether they perform their intended functions adequately and consistently as specified. The Major Phases of validation include Pre validation, Process Validation and Validation maintenance Phase.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; IVT’s 22nd Annual Validation Week, October 18–20, 2016, San Diego, USA; IVT’s 2nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; Analytical Procedures and Methods Validation EU, June 21-23, 2016, Dublin, Ireland; IVT’s ACE Conference, August 22-24, 2016, Philadelphia, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-9: Contract & Sterile/Aseptic Manufacturing

Traditional role of Contract manufacturing, also known as outsource manufacturing, is to produce one or more components of a final product in which a company relies on the skills of specialist manufacturers. Six Sigma is a long-term, forward-thinking initiative designed to fundamentally change the way corporations do business. It is first and foremost "a business process that enables companies to increase profits dramatically by streamlining operations, improving quality, and eliminating defects or mistakes in everything a company does. Aseptic/sterile production and injectable manufacturing processes require a significant investment in terms of expertise, equipment, process, technology and quality control.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6th 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; Asia-Pacific Drug Formulation & Bioavailability Congress, June 6-8, 2016, Beijing, China; 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. Canadian Society for Pharmaceutical Sciences (CSPS), Drug Information Association (DIA), Society for Pharmaceutical Engineering (ISPE), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-10: Storage, Distribution, Transportation

Cold chain storage is a temperature-controlled supply chain. An unbroken cold chain is an uninterrupted series of storage and distribution activities which maintain a given temperature range. It is used to help extend and ensure the shelf life of pharmaceutical drugs. Good distribution practice (GDP) deals with the guidelines for the proper distribution of medicinal products for human use. GDP is a quality warranty system, which includes requirements for purchase, receiving, storage and export of drugs intended for human consumption. Supply Chain integrity, enable qualified firms to expedite the importation of active pharmaceutical ingredients and finished drug products.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6th 6th Pharmaceutical Conference on Regulatory Affairs and IPR, September 12-14, 2016, San Antonio, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; Interest Group Meeting on Pharmaceutical Good Cold Chain, October 10, 2016, Amsterdam, The Netherlands: 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Canadian Generic Pharmaceutical Association (CGPA).

Track-11: Formulation Development

Formulation development is to be done only after successful completion of pre-formulation studies. Optimization of existing formulations is required to create new products, Reduce costs, to capitalize on trends with greater profitability, novel formulations for improved delivery of existing dosage forms, to quickly recalculate formulations based on defined criteria, to create compliant products faster by using existing validated formulas. Product/Process optimization is the practice of making changes or adjustments to a process such as Conjoint Analysis, typically used in industrial process optimization.

Related Conferences:

Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; Biopharmaceutics Conference, September 14-16, 2016, San Antonio, USA; 10th Conference on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017, London, UK; 6th Asia-Pacific Pharma Congress, July 11-13, 2016, Kualalumpur, Malaysia; 9th World Drug Delivery Summit, June 30-July 02, 2016, New Orleans, USA; Asia-Pacific Drug Formulation & Bioavailability Congress, June 6-8, 2016, Beijing, China; 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. The European Personalized Medicine Association (EPEMED), The Institute of Clinical Research (ICR), The BioIndustry Association (BIA), Canadian Generic Pharmaceutical Association (CGPA), The British Generic Manufacturers Association.

Track-12: GMP in Food Industry

The Quality control in typical food processing has a significant role in assuming a high quality, safe and nutritious food supply for the public, for their good health and for the economic benefits derived from trade of safe and high quality food. Quality control conference also plays a major role in food industry. Hazard Analysis & Critical Control Points (HACCP) is a management system in which food safety is addressed through the analysis and control of biological, chemical, and physical hazards from raw material production, procurement and handling, to manufacturing, distribution and consumption of the finished product. Food, Drug, and Cosmetic Act is a set of laws giving authority to the US-FDA to oversee the food safety, safety of drugs, and cosmetics. Cleaning, disinfection and hygiene should be strictly maintained in food industry.

Related Conferences:

10th Global Food Processing Summit, December 5-7, 2016, San Antonio, USA; Pharma Marketing Conference, November 10-11, 2016, Alicante, Spain; 2nd Conference on Food Safety and Regulatory Measures, June 06-08, 2016, London, UK; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 5th Conference on Global Food Safety, December 05- 07, 2016, San Antonio, USA; 18th IUFOST – World Congress of Food Science and Technology, August 21-25, 2016, Dublin, Ireland; 12th Conference on Food Studies - A Common Ground Conference, October 12-13, 2016 Berkeley, USA; 3rd Conference on Food Sciences and Health (ICFSH 2016), November 26-28, 2016, Sydney, Australia; Conference on Nutrition and Food Engineering (ICNFE 2016), August 19-21, 2016, Budapest, Hungary; Conference on Biotechnology, Food Science, and Pharmaceutical Research, August 3-5, 2016, Kuala Lumpur, Malaysia. Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-13: GMP in Microbiology and Biotechnology

Microbiological Assay is defined as the determination or estimation of concentration or potency of an antibiotic by means of measuring and comparing the area of zone of inhibition or turbidity produced by test substance with that of standard over a suitable microbe under standard conditions. FDA 510k Testing regulation is found in 21 CFR 807 includes information required in a 510(k). The 510(k) is not a form. Cleaning, disinfection and hygiene should be strictly maintained in Microbiology and Biotechnology.

Related Conferences:

Conference on Food Microbiology, August 08-10, 2016, Birmingham, UK; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 11th World Congress on Biotechnology and Biotech Industries, July 28-29, 2016, Berlin, Germany; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; Biotechnology World Convention, August 15-17, 2016, Sao Paulo, Brazil; 5th Conference on Clinical Microbiology and Microbial Genomics, October 24-26, 2016, Rome, Italy; Conference on Biotechnology, Food Science, and Pharmaceutical Research, August 3-5, 2016, Kuala Lumpur, Malaysia; Conference of Chemical, Pharmaceutical & Medical Sciences (ICCPMS), December 24-25, 2016, New Delhi, India; Conference on Nanotechnology (ICNT 2016), September 10-12, 2016, Kuala Lumpur, Malaysia; 11th Annual PDA Global Conference on Pharmaceutical Microbiology, October 26-27, 2016, Arlington, USA. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Austrian Pharmaceutical Society (APS).

Track-14: Softwares in GMP and GCP

The use of GMP software systems in regulated industries is vital throughout all aspects of the manufacturing process. Quality management software provides a flexible and configurable platform for tracking and managing quality and regulatory compliance events to ensure that manufacturing activities are continually measured, monitored and improved upon.  In addition to managing all aspects of the audit process, GMP software solution manages the associated findings or observations, corrective and preventive actions (CAPAs), risk assessment, risk management and the analysis and approvals of changes. This software also manages deviations, process validation, complaint handling, manufacturing incidents, training records and more.

Related Conferences:

7th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; 2nd  Separation Techniques Conference, Oct 31 - Nov 2, 2016, Valencia, Spain; Conference on Generic Drug Market and Contract Manufacturing, Nov 07- 09, 2016 Barcelona, Spain; 6th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Pharmaceutical Method Development and Validation Conference November 24-25, 2016 Dubai, UAE; IVT’s Computer and Software Validation (CSV) EU, December 1-3, 2016, Amsterdam, The Netherlands; R&D Financial Tracking and Analysis Summit, November 16-17, 2016, Philadelphia, PA; Data Integrity Validation, September 17-18, 2016, San Diego, CA; IVT’s 2nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Japan Generic Pharmaceutical Manufacturers Association, Association of the British Pharmaceutical Industry, Pharmaceutical Association for the Development of the Republic of China (CPMDA), The Danish Association of the Pharmaceutical Industry, Belgian Pharmaceutical Industry Association.

Conference Series LLC Conferences invites all the participants from all over the world to attend ‘5th International Summit on GMP, GCP & Quality Control (GMP Summit 2016)' held during August 12-13, 2016 at Toronto, Canada which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality.

The main theme of the conference is “Taking on challenges and exploring opportunities to achieve Compliance and ensuring great Quality Products”.

Good manufacturing practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Advanced studies are being made to improvise quality of products, reduce safety risk and cost, and enhance international credibility and public image and many more.

Conference Series LLC organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals and conducting over 3000 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, over 70000 eminent personalities, reputed scientists as editorial board members. To know more about the conference series visit: http://www.conferenceseries.com/

 

Why to attend???

With members from around the world focused on learning about Good Manufacturing Practices and quality standards; this is your best opportunity to reach the largest assemblage of participants from the GMP community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with current quality standards, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in related to GMP are hallmarks of this conference.

Target Audience:

  • Pharmaceutical Industries
  • Food Industries
  • Biotechnology Industries
  • Manufacturing Companies
  • Pharmaceutical Faculty
  • Pharmacy Associations and Societies
  • Pharmaceutical Researchers
  • Pharmaceutical students, scientists
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Data Management Companies

Summary:

GMP Summit 2016 welcomes attendees, presenters, and exhibitors from all over the world to Toronto, Canada. We are delighted to invite you all to attend and register for the “5th International Summit on GMP, GCP & Quality Control (GMP Summit 2016) which is going to be held during August 12-13, 2016 at Toronto, Canada. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the GMP Summit 2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of GMP Summit 2016 organizing committee look forward to meet you at Toronto, Canada.

Importance and Scope:

Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Advanced studies are being made to improvise quality of products, reduce safety risk and cost, and enhance international credibility and public image and many more.

Why Toronto, Canada?

By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making Canada the 9th largest world market. The Canadian pharmaceutical industry is undergoing tremendous challenges. In 2011 the Canadian market was the 8th largest in the world and accounted for 2.6% of total global purchases.

Toronto itself is a home of many pharmaceutical industries such as Abbott Products Inc., Novapharm Limited, Quality Systems Technologies, Rivex Pharma Inc., Pharmax Limited, Oxalys Pharmaceuticals, and universities like University of Toronto, Ryerson University, York University, etc,. Toronto is also a famous tourist destination. The major attraction includes CN Tower, Royal Ontario Museum, Rogers Centre, Art Gallery of Ontario, Casa Loma, City Hall, Eaton Center, High Park, Ontario Science Centre and Toronto Islands.

 Conference Highlights

  • Good Manufacturing Practices: The Gap within
  • Current Regulations and Quality Standards
  • Current GMP Guidelines (cGMP)
  • The Role of c in cGMP
  • Good Clinical Practices & Good Laboratory Practices
  • Quality Control
  • Quality Assurance
  • Validation
  • Contract & Sterile/Aseptic Manufacturing
  • Storage, Distribution, Transportation
  • Formulation Development
  • GMP in Food Industry
  • GMP in Microbiology and Biotechnology
  • Softwares in GMP and GCP

Societies Associated with Pharma manufacturing Industries

City (Toronto):

  • Society for Industrial Microbiology and Biotechnology
  • Canadian Generic Pharmaceutical Association
  • Canadian Association for Pharmacy Distribution Management (CAPDM)

Country (Canada):

  • Canadian Association of Professionals in Regulatory Affairs
  • Canadian Medical Association 
  • Canadian pharmacists Association
  • Canadian Generic Pharmaceutical Association
  • The Neighbourhood Pharmacy Association of Canada
  • National Association of Pharmacy Regulatory Authorities

Worldwide (International):

  •       Institute of Pharmacy Management International (IPMI)
  •       International Academy of Compounding Pharmacists (IACP)
  •       International Association for Pharmaceutical Technology (APV)
  •       International eHealth Association
  •       International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
  •       International Federation of Pharmaceutical Wholesalers (IFPW)
  •       International Pharmaceutical Excipients Council (IPEC)
  •       International Pharmaceutical Federation (FIP)
  •       International Pharmaceutical Students Federation (IPSF)
  •       International Society for Medical Publication Professionals (ISMPP)
  •       International Society of Oncology Pharmacy Practitioners (ISOPP)
  •       International Society for Pharmaceutical Engineering (ISPE)
  •       International Society for Pharmacoepidemiology (ISPE)
  •       International Society for the History of Pharmacy (ISHP)
  •       International Society for the Study of Xenobiotics (ISSX)
  •       International Society of Pharmaceutical Compounding (ISPhC)
  •       International Young Pharmacists' Group (YPG)
  •       Parenteral Drug Association (PDA)
  •       Regulatory Affairs Professionals Society (RAPS)
  •       Society for Biomolecular Sciences (SBA)
  •       Controlled Release Society

Statistical Representation:

List of Pharmaceutical Industries in Toronto

City (Toronto)

Abbott Products Inc.

Acanthus Research Inc.

Alveda Pharmaceuticals Inc.

Berkeley BioPharma

CHP Pharma Inc.

Cervelo Pharmaceuticals, Inc.

Debro Pharma Inc.

Global Pharm Inc.

Global Quality Institute

GlycoBioSciences Inc.

GxPharma.ca

Imutec Pharma Inc

Innopharm Inc.

Innovalinks Quality Consultant

Intermune Life Sciences, Inc.

Jaapharm Canada Inc.

KRIM Biopharma Inc.

Novapharm Limited

ORx Pharmaceutical Corporation

Oxalys Pharmaceuticals, Inc.

PharmaSeam Inc.

Pharmax Limited

Prempharm Inc.

Q&R Canada Inc.

Quality Systems Technologies

Rivex Pharma Inc.

Talecris Biotherapeutics Ltd

 

Country (Canada)

Janssen Inc

Dalton Pharma Services

Alveda Pharma

Astrazeneca

Genpharm Inc.

BioPharma Services Inc

Purdue Pharma

Teva Canada Ltd

Devik Pharma Inc.

TNO - Pharma Noord Amerika

Ranbaxy Pharmaceuticals Canada Inc

Pfizer Canada

Shire HGT Canada

Wyeth Pharmaceuticals division of Pfizer Canada Inc.

Ferring Inc

Nucro-Technics

Bayer

Astellas Pharma

Attix Pharmaceuticals

Nuvo Research Inc.

Sun Pharmaceutical Industries Inc

NPS Pharmaceuticals

Pfizer Consumer Health Care

Nucro-Technics

Forest Laboratories Canada Inc.

Bromed Pharmaceuticals Inc

Medical Futures Inc.

Taro Pharmaceuticals Inc.

Cipher Pharmaceuticals

Abbott Laboratories LTD

Attix Pharmaceuticals

Sanofi Pasteur

Polydex Pharmaceuticals Ltd

Dextran Products Ltd

Eli Lilly

Neil Med Product Inc

Highland Therapeutics Inc

Cynapsus

Affinium Pharmaceuticals

Mint Pharmaceuticals Inc.

McKesson Canada

Oxalys Pharmaceuticals

Vertex Pharmaceuticals

PharmaCommunications Group Inc.

Johnson & Johnson

ZS Associates

AA Pharma inc

Nutralab Canada

PharmEng Technology Inc

Pharma Medica Research

Rexall Drug Stores Ltd

Octapharama Canada Inc

Bristol Myers Squibb

Medisystem Pharmacy Inc

ALK Pharmaceuticals Inc

Generex Biotechnology Corporation

Novo Nordisk Canada Inc

Loblaw Companies Limited

Cedarcourt Pharmasave

Actavis Specialty Pharmaceuticals Co

Brand Institute Canada

IDA Danforth Drug Mart

Solvay Pharma Inc

SteriMax Inc.

Trimel Pharmaceuticals Corporation

Johnson Matthey Ltd

Gilead Sciences Canada, Inc.

PharmEng Technology Inc

Apotex Inc

McKesson Canada Inc

Actavis Pharma Company

GlaxoSmithKline Inc

Amgen Canada Inc

Sepracor Pharmaceuticals Inc

Patheon Inc.

Novartis

WellSpring Pharma Services

Takeda Canada Inc

Hoffmann-La Roche Limited

Pharmasave

Ucb Canada Inc

Serono Canada Inc

Concordia Healthcare Corp.

IMS Brogan

Intertek Cantox

Boehringer Ingelheim (Canada) LTD

Becton & Dickinson

Patheon Inc

Patheon Inc-Burlington Century Operations

Contract Pharmaceuticals Limited

Therapure Biopharma Inc.

Q Pharm Inc

QPharm

Novopharm LTD

Worldwide :

Abbott Laboratories

Almirall

AbbVie

Alphapharm

Acadia Pharmaceuticals

Altana Pharma AG

Actavis

Amgen

Actelion

Amico Laboratories

Advaxis

Anavex Life Sciences

Ajanta Pharma

Apotex Inc.

Alcon

Astellas Pharma

Alexion Pharmaceuticals

AstraZeneca

Alkaloid

Avax Technologies

Alkermes

Avella Specialty Pharmacy

Allergan

Axcan Pharma

Alliance Boots

Aurobindo Pharma

Bargn Farmaceutici Phils Co

Cadila Healthcare

Barr

Celgene

Basi

Cephalon

Bausch & Lomb

Chiesi Farmaceutici S.p.A.

Baxter International

Chugai Pharmaceutical Co.

Bayer Schering Pharma AG

CinnaGen

Beximco Pharmaceuticals Ltd

Cipla

Bial

CoCo Therapeutics

Biocon

Covance

Biogen Idec

Crucell

Biolex

CSL Limited

Bionovo

Daiichi Sankyo

Biotecnol

Dainippon Sumitomo Pharma

Biovail

Dawakhana Shifaul Amraz

Biovitrum

Debiopharm

Bluepharma

Diabetology Ltd

Boehringer-Ingelheim

Diffusion Pharmaceuticals

Bosnalijek

Dr. Reddy's Laboratories

Bristol-Myers Squibb

Ego Pharmaceuticals

Help Remedies

Eisai (company)

Hetero Drugs

Elder Pharmaceuticals

Hexal Australia

Eli Lilly and Company

Hikma Pharmaceuticals

Elorac, Inc.

Hoffmann–La Roche

Emergent BioSolutions

Hovione

Endo Pharmaceuticals

Ipca Laboratories

Eskayef Bangladesh Limited

Incepta Pharmaceuticals

F. Hoffmann–La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals

Institute for OneWorld Health

Ferring Pharmaceuticals

Intas Biopharmaceuticals

Fresenius Kabi

Intercytex

Fresenius Medical Care

Interphil Laboratories

Galderma Laboratories

Janssen Pharmaceutica Products, a subsidiary of Johnson & Johnson

Getz Pharma

Jenapharm, a subsidiary of Bayer Schering Pharma

Gilead Sciences

JN-International Medical Corporation

GlaxoSmithKline

Johnson & Johnson

Glenmark Pharmaceuticals

Julphar

GPC Biotech

Lupin Limited

Grifols

Menarini

Gulf Pharmaceutical Industries (Julphar)

Merck & Co.

3M Pharmaceuticals

Merck KGaA

MannKind Corporation

Mitsubishi Pharma

McGuff

Mylan

Medinfar

Novartis

Melior Discovery

Novo Nordisk

NovaBay Pharmaceuticals

Noxxon

Octapharma

Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson

Orexo

Otsuka Pharmaceutical Co.

Orion Pharma

Pharmacosmos

Panacea Biotec Ltd

Pierre Fabre Group

Par Pharmaceutical

Piramal Healthcare

Patheon

Pliva

Perrigo

Procter & Gamble

Pfizer

Purdue Pharma

Pharma Medica

Renovo

Pharma Nord

Respa Pharmaceuticals

Gedeon Richter Ltd.

Rubicon Research

Ranbaxy Laboratories, generics arm of Daiichi Sankyo

Reckitt Benckiser

Regeneron Pharmaceuticals

Solvay Group

Salix Pharmaceuticals

Square Pharmaceuticals

Sanofi

STADA Arzneimittel

Sunovion

Strides Arcolab

Serum Institute of India

Sun Pharmaceutical

Servier Laboratories

Takeda Pharmaceutical Co.

Shionogi

Tasly

Shire plc

Teva Pharmaceuticals

Sigma Pharmaceuticals

Torrent Pharmaceuticals

Sinopharm Group

Vertex Pharmaceuticals

UCB

Vion Pharmaceuticals, Inc.

Unichem Laboratories

Wallace Pharmaceuticals

UNILAB, also known as United Laboratories

Wockhardt

Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals

Yuhan Corporation

VAV Life Sciences

Zandu Pharmaceuticals

Veloxis Pharmaceuticals

Zentiva

 

Statistical Representation:

Target Audience:

The target audience will from the pharmaceutical, food, and biotechnology industries in Canada, associations and societies of Canada, students and professors from the academia of the various universities, researchers, scientists, experts, business delegates in the field of Pharmaceutical Sciences. 

Global Market Analysis for GMP:

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Statistical Representation

Canada Statistics:

  • The Canadian Pharmaceutical market was the 8th largest in the world by 2020.
  • Canada’s pharmaceuticals industry accounts for about 2.6% of the global pharmaceutical industry.
  • Industry revenues are expected to expand at a CAGR of 2.5% during 2015-18 in Canada.
  • The impact of the patent cliff will be less of a drag on Canadian market growth as the value of patent losses is expected to taper-off after 2012, stabilizing to below $500 million by 2017.

GLOBAL Statistics:

  • Global spending on medicines is forecast to reach nearly $1.3 trillion by 2018
  • 21 pharmerging countries will increase their contribution to growth over the next five years and account for nearly 50% of absolute growth in 2018.
  • The pharmerging markets will expand at a compound annual growth rate of 8-11% through 2018
  • Total global spending will reach $1.3 trillion in 2018, an increase of $290-320 billion from 2013, driven by population growth, an aging population, and improved access in pharmerging markets.
  • A compound annual growth rate of 4-7% on a constant currency basis, will be slightly higher than the 5.2% recorded over the past five years

Funds allotted to Pharmaceutical Research:

Worldwide:

Pharmaceutical companies have traditionally funded their internal R&D efforts totally on their own by investing 15% or more of their top line revenues to pay for these endeavours’. In addition, in order to tap into R&D going on outside their companies, pharmaceutical companies has financially supported external R&D efforts in deals with small biotech companies, research institutes, and universities. In fact, as funding for agencies like the NIH has stagnated over recent years, pharma has become an important source of funds to support early stage research.

The R&D Funding Forecast notes that there is a continuing shift in where R&D investments are being made, with fewer in the U.S. and Europe and more in Asian countries. The U.S. now accounts for less than a third of global spending, while Europe’s 34 countries account for less than 22% and Asian countries account for nearly 40%, a trend that has continued for the past five years. This trend is expected to continue through the end of the decade with China’s R&D investments surpassing those of the U.S. by about 2022.

Members Associated with Pharmaceutical Research:

In regard to Industrial personnel:

Research Positions:-

  • Lab technician
  • Research Associate
  • Research Scientist

Clinical Development and medical Jobs:

  • Clinical Research Physician
  • Clinical Research Associate
  • Regulatory Affairs Associate
  • Bio Statistician
  • Clinical Data Manager
  • Medical Science Liaison

Manufacturing and Quality Assurance Jobs:

  • Process Engineer
  • Quality Control Analyst
  • Quality Assurance Specialist

Business Operations Jobs:

  • Market research Analyst
  • Associate Product Manager
  • Product Manager
  • Strategy Director
  • Business Development Manager
GMP Summit 2015

We gratefully thank all our wonderful speakers, conference attendees, students, associations and exhibitors for making GMP Summit 2015 Conference the best ever!

Previous GMP Summit 2015 conference for the PHARMA sector was organized by Conference Series LLC (that organizes highly notable Pharmaceutical conferences throughout the globe) in 2015 in Hyderabad, India.

Since then an annual conference has been organized by Conference Series LLC in various locations around the globe.

In 2015, the conference took a new direction, broadening its focus on the GMP in Food industry, Biotech and Healthcare industry. This has provided a unique opportunity for academic and industry-wide communication and collaboration and has positioned the conference as the OMICS International's annual Pharma market premier event.

The 4th International Summit on GMP, GCP and Quality Control, hosted by the Conference Series LLC was held during October 26-28, 2015 at HICC Novotel, Hyderabad, India based on the theme New Paradigm Approach for Manufacturing Excellence and Quality Standards ". Benevolent response and active participation was received from the Editorial Board Members of Conference Series LLC Journals along with scientists, researchers, students and leaders from various fields like Pharma, Biotech and Food industry, who made this event a grand success.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • David Spaulding, SeerPharma, Australia
  • Shivraj Dasari, SLS Cell Cure Technologies Private Limited., India
  • Sunil Kumar Verma, CSIR-Centre for Cellular and Molecular Biology (CCMB), India
  • Peter D Smith, Parexel International, USA
  • Rama K Pidaparti, Wipro Technologies, USA
  • Tanmoy Chakraborty, Manipal University Jaipur, India

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Good Manufacturing Practices: The Gap within
  • Current Regulations and Quality Standards
  • Current GMP Guidelines (cGMP)
  • The Role of 'c' in cGMP
  • Good Clinical Practices & Good Laboratory Practices
  • Quality Control
  • Quality Assurance
  • Validation
  • Contract & Sterile/Aseptic Manufacturing
  • Storage, Distribution, Transportation
  • Formulation Development
  • GMP in Food Industry
  • GMP in Microbiology and Biotechnology

Conference Series LLC offers its heartfelt appreciation to organizations such as Parexel InternationalSeerPharma and esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. OMICS International also took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

With the grand success of GMP Summit 2015, Conference Series LLC is proud to announce the "5th International Summit on GMP, GCP and Quality Control" to be held during August 01-02, 2016 at Toronto, Canada.

2016 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

For More details visit: http://gmp-gcp-quality-control.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

GMP Summit-2014
3rd International Summit on GMP, GCP & Quality Control was successfully held on September 25-26, 2014, Valencia Convention Centre, Spain, with a theme "Manufacturing and Quality Guidelines; Training and Beyond" which tracked the evolution in manufacturing and quality guidelines. GMP Summit-2014 brought together the International blend of people from pharmaceutical, biotech & medical devices companies, business entrepreneurs, pharmaceutical consultants, leading universities and research institutions making it the largest endeavor from Conference Series LLC. All the papers presented at this conference were published in special issue of Journal of Developing Drugs: Open Access.

GMP Summit-2014 opened up new vistas and fostered collaborations in the industry and academia.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

  • Victor Sanchez, Pharma-Bio Serv S.L., Spain
  • Sundar Chellamani, SysComm Project Management Limited, Ireland
  • María Pellín Amorós, Laboratoires Quinton International S.L., Spain
  • Rama K Pidaparti, Wipro Technologies, USA
  • David L Chesney, Parexel International, USA
  • Wael Ebied, SEDICO Pharmaceuticals-Merck & Co., Egypt
  • Aziz Chraibi, Pharma Bio Expert Inc., Canada

Workshop: A workshop on “Natural Health Products site licensing in Canada: How to meet the GMPs regulations” conducted by Jalal Mokhalalati, Quality Medical Regulations Services, Canada.

Workshop: A workshop on “Best practices for internal and supplier auditing” conducted by David L Chesney, Parexel International, USA.

Workshop: A workshop on “ICH Q9 risk management applied to the compliance challenges between cGMP & safety design issues in manufacturing pharmaceutical & biotechnology facilities” conducted by Aziz Chraibi, Pharma Bio Expert Inc., Canada.

Our special gratitude to our Collaborations and Exhibitors Telstar, Spain; AEFI, Spain; FEBiotec, Spain.

Conference Series LLC has taken the privilege of felicitating GMP Summit -2014 Organizing Committee, Keynote Speakers and business delegates who supported for the success of this event.

Following on the heels of this successful event we are excited to announce 4th International Summit on GMP, GCP & Quality Control Slated on October 26-28, 2015, at Hyderabad, India, with a theme “New Paradigm Approach for Manufacturing Excellence and Quality Standards” and wish that with your overwhelming support for GMP Summit 2015 will become an outstanding event.


Past Reports  Proceedings  Gallery  

GMP-2013
GMP-2013 Report

2nd International Summit on GMP, GCP & Quality Control was successfully held on November 12-14, 2013, DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, USA, with a theme "Ensuring the Quality standards of Manufacturing process" which tracked the evolution in manufacturing and quality guidelines. GMP-2013 brought together the International blend of people from pharmaceutical, biotech & medical devices companies, business entrepreneurs, pharmaceutical consultants, leading universities and research institutions making it the largest endeavor from Conference Series LLC. All the papers presented at this conference were published in special issue of Journal of Developing Drugs: Open Access.

GMP-2013 opened up new vistas and fostered collaborations in the industry and academia.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

  • Ashraf Youssef, AYPharma Safety Consulting, LLC., USA
  • Gerard Pearce, SQA Services, Inc., USA
  • Myriam Ochart, Lean Compliance Partners, USA
  • James Huang, Forest Laboratories, Inc., USA
  • Patricia Henley, London School of Hygiene & Tropical Medicine, UK

Workshop: A workshop on “Zippy Lean Workshop (Production Line Simulation)” conducted by Myriam Ochart, Lean Compliance Partners, USA & Jennifer Leny, American Society for Quality, USA.

Workshop: A workshop on “Highlights of Process Analytical Technology (PAT) & FDA Directives” conducted by Shib Mookherjea, ValQual International, USA.

Conference Series LLC has taken the privilege of felicitating GMP -2013 Organizing Committee, Keynote Speakers and business delegates who supported for the success of this event.

Conference Series LLC, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance in the field of Pharma regulatory affairs and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. Our warm gratitude to our sponsors, exhibitors & media partners for associating with the conference.

Following on the heels of this successful event we are excited to announce 3rd International Summit on GMP, GCP & Quality Control Slated on September 25-26, 2014, at Valencia Convention Center, Spain, with a theme Manufacturing and Quality Guidelines; Training and Beyond” and wish that with your overwhelming support for GMP Summit -2014 will become an outstanding event.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 12-13, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
gmpsummit@omicsgroup.com
Sponsors / Exhibiting / Advertising.
gmpsummit@conferenceseries.net
General Queries.
gmpsummit@conferenceseries.com

View Proceedings of Previous Conferences

GMP Summit 2014 Conference Proceedings
GMP Summit 2015 Conference Proceedings
GMP Summit 2013 Conference Proceedings
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.